Natural News
FDA sets “dangerous precedent” disregarding their own scientific panel
The Food and Drug Administration (FDA) recently approved a new Alzheimer’s drug even though their expert review panel rejected the fraudulent end points that were used to promote the drug’s “efficacy!” Even though the three-member panel voted unanimously against the drug, the agency overruled their expert scientific analysis and approved the new drug anyway, opting to rely on a separate measure promoted by the drug company itself. In protest, the three FDA advisors resigned from their positions, leaving bare the FDA’s compromised state and scientific fraud.
READ FULL ARTICLE HERE > https://www.naturalnews.com/2021-06-14-no-fda-expert-voted-approve-new-alzheimers-drug.html